Oncology is buying at star treck warp speed, not being sold off or bought out. Oncology is the most profitable division in Pfizer by a mile over #2 Vaccine profit. IM thousands reps low profit as the biggest product Eliquise is owned by BMS & they get 60% of gross . Rare Disease while promising is a wash. Xeljanz is a cash cow but rapidly falling like a meteorite. Derm is a loss looser with Eucrisa.
